Sygnis SA (WSE:SYG)
2.560
+0.060 (2.40%)
Last updated: Jan 5, 2026, 9:00 AM CET
Sygnis Market Cap
Sygnis has a market cap or net worth of 71.86 million as of January 7, 2026. Its market cap has increased by 613.47% in one year.
Market Cap
71.86M
Enterprise Value
75.76M
Revenue
15.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.56
Market Cap Chart
Since March 16, 2012, Sygnis's market cap has increased from 6.21M to 71.86M, an increase of 1,057.38%. That is a compound annual growth rate of 19.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 70.21M | 18.52% |
| Dec 30, 2025 | 59.24M | 501.78% |
| Dec 30, 2024 | 9.84M | -56.47% |
| Dec 29, 2023 | 22.62M | -56.95% |
| Dec 30, 2022 | 52.54M | 10.53% |
| Dec 30, 2021 | 47.53M | 177.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.44B |
| Voxel | 1.35B |
| Celon Pharma | 1.12B |
| Selvita | 805.81M |
| Ryvu Therapeutics | 635.80M |
| Centrum Medyczne ENEL-MED | 509.05M |